HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful Total En Bloc Spondylectomy of T7 Vertebra for Hepatocellular Carcinoma Metastasis After Living Donor Liver Transplantation.

AbstractSTUDY DESIGN:
Case report.
OBJECTIVE:
We report a patient who was successfully treated with total en bloc spondylectomy (TES) for T7 metastasis after living donor liver transplantation for hepatocellular carcinoma (HCC).
SUMMARY OF BACKGROUND DATA:
Spinal metastasis from HCC has a poor prognosis. There are only a few studies on surgical outcomes of spinal metastasis from HCC. Because of the high surgical morbidity and short life expectancy in patients with HCC with spinal metastasis, TES is not considered in these patients, although several studies have reported satisfactory results for TES for some types of metastatic spinal tumors. Liver transplantation (LT) is the curative treatment option for early HCC. However, the recurrence of HCC is a possible problem after LT, although no reports on surgery for spinal metastasis following LT for HCC have been published. We report on the first case of a patient who was successfully treated with TES for T7 metastasis after living donor LT for HCC.
METHODS:
The patient was a 65-year-old man, who had undergone living donor LT for HCC 2 years before. His main symptom was progressive gait disturbance because of the spinal cord compression by the tumor at T7. Radiology and pathology examinations revealed a solitary metastasis at T7 with neither recurrence in the liver nor metastasis in the other organs. We performed TES using a pedicle screw system and a mesh cage filled with frozen autografts.
RESULTS:
After surgery, the patient showed clear improvement in neurological symptoms. At 3 months after surgery, a T4 metastasis was detected with magnetic resonance imaging, and the patient was treated with heavy ion radiotherapy. He could walk without a cane and there was no evidence of recurrence at 1.5 years after surgery.
CONCLUSIONS:
Solitary spinal metastasis of HCC may become an indication for TES if liver function improves after LT.
LEVEL OF EVIDENCE:
5.
AuthorsHiroaki Kimura, Shunsuke Fujibayashi, Takayoshi Shimizu, Bungo Otsuki, Hideki Murakami, Toshimi Kaido, Shinji Uemoto, Shuichi Matsuda
JournalSpine (Spine (Phila Pa 1976)) Vol. 40 Issue 16 Pg. E944-7 (Aug 15 2015) ISSN: 1528-1159 [Electronic] United States
PMID25893346 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Bone Neoplasms (radiotherapy, secondary, surgery)
  • Carcinoma, Hepatocellular (secondary, surgery)
  • Humans
  • Liver Neoplasms (pathology, surgery)
  • Liver Transplantation
  • Living Donors
  • Male
  • Thoracic Vertebrae (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: